Riluzole (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Riluzole drug offered from KAISER FOUNDATION HOSPITALS. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Riluzole
SUBSTANCE NAME: RILUZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-05-14
END MARKETING DATE: 0000-00-00


Riluzole HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRiluzole from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2014-05-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0150_a361dab4-4407-4297-83e9-45e1ab7d3df1
PRODUCT NDC: 0179-0150
APPLICATION NUMBER: ANDA091417

Other RILUZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingRILUZOLE
Apotex CorpRILUZOLE
Ascend Laboratories, LLCRiluzole
Covis PharmaRilutek
Covis Pharmaceuticals, Inc.Rilutek
Glenmark Pharmaceuticals Inc., USAriluzole
KAISER FOUNDATION HOSPITALSRilutek
Mylan Pharmaceuticals Inc.Riluzole
Rising Pharmaceuticals, Inc.Riluzole
sanofi-aventis U.S. LLCRilutek
Sun Pharmaceutical Industries LimitedRiluzole